|
The members of GA RP Collections
that share beneficial ownership of the Class A ordinary shares held of record by GA RP Collections are indirectly held by the following
General Atlantic investment funds, (the “GA Funds”): GAP AIV-1 A, GAP AIV-1 B, GAPCO CDA,
GAPCO III, GAPCO IV and GAPCO V. GA SPV is the sole non-member manager of GA RP Collections. The general partner of GAP AIV-1 A
and GAP AIV-1 B is GA GenPar. The general partner of GA GenPar is GA LLC. GA LLC is the sole member of GA SPV, the managing
member of GAPCO III, GAPCO IV and GAPCO V and the general partner of GAPCO CDA. The limited partners that share beneficial ownership
of the Class A ordinary shares held by GA RP Holding are the following General Atlantic investment funds: GAP EU, GAP IV, GAP Lux,
GAPCO III, GAPCO IV, GAPCO V and GAPCO CDA. The general partner of GAP Lux is GA GenPar Lux and the general partner of GA GenPar
Lux is GA Lux. The general partner of GAP EU, GAP IV and GA Lux is GenPar Bermuda. GAP (Bermuda) Limited is the general partner
of GenPar Bermuda. The general partner of GA RP Holding is GA RP Holding, Ltd. (“GA RP Holding, Ltd.”). GAP (Bermuda)
Limited is the sole shareholder of GA RP Holding, Ltd. As of the date hereof, there are nine members of the management committee
of GA LLC (the “GA Management Committee”). The members of the GA Management Committee are also members of the
management committee of GAP (Bermuda) Limited. GA LLC, GAP (Bermuda) Limited, GA RP Holdings Ltd., GenPar Bermuda, GA Lux, GA GenPar
Lux, GAP Lux, GAP IV, GAP EU, GA GenPar, GA SPV, GAP AIV-1 A, GAP AIV-1 B, GAPCO III, GAPCO IV, GAPCO V, GAPCO CDA are a “group”
within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934, as amended. Each of the members of the GA Management Committee
disclaims ownership of the Class A ordinary shares except to the extent he or she has a pecuniary interest therein. The
name, the business address and the citizenship of each of the members of the GA Management Committee as of the date hereof is attached
hereto as Schedule A and is hereby incorporated by reference.
Amount Beneficially Owned:
By virtue of the relationship described above, each of the Reporting
Persons may be deemed to beneficially own the Class A ordinary shares indicated on row (9) on such Reporting Person’s cover
page included herein.
Percentage Owned:
All calculation of percentage ownership herein are based on an aggregate
of 412,876,270 Class A ordinary shares outstanding, consisting of (i) 388,132,400 Class A ordinary shares reported by the Company
to be outstanding as of November 10, 2020 as reflected in the Company’s Quarterly Report on Form 10-Q filed with the U.S.
Securities and Exchange Commission on November 12, 2020 and (ii) 24,743,870 Class A ordinary shares issuable upon conversion of
Class B Interests of Royalty Pharma Holdings Ltd, a subsidiary of the Company, held by GA RP Collections.
Number of Shares as to Which Such Person Has Sole/Shared Power
to Vote or to Direct the Vote and Sole/Shared Power to Dispose or to Direct the Disposition of:
|